References
- Battistini F., Bolivar C., Zaias N., Sierra R., Rebel G. Clinical antifungal activity of thiabendazole. Archives of Dermatology 1974; 109: 695–699
- Bayles M.A.H. Chromomycosis. Treatment with thiabendazole. Archives of Dermatology 1971; 104: 476–485
- Blank H., Rebel G. Thiabendazole activity against the fungi of dermatophytosis, mycetomas and chromomycosis. Journal of Investigative Dermatology 1965; 44: 219–220
- Carr J.F., Lewis C.W. Tinea nigra palmaris. Treatment with thiabendazole topically. Archives of Dermatology 1975; 111: 904–905
- David J.R., David R. Assay for inhibition of macrophage migration. In vitro methods in cell-mediated immunity, B.R. Bloom, P.R. Glade. Academic Press, Inc., New York 1971; 247–261, In
- Fleischmajer R.J., Goldstein J., Nicholas K. Preliminary report on the antimycotic effect of topical thiabendazole “in vivo”. Current Therapeutic Research 1965; 7: 558–561
- Howard D.H. Observations on tissue cultures of mouse peritoneal exudates inoculated with Histoplasma capsulatum. Journal of Bacteriology 1959; 78: 69–78
- Howard D.H. Effect of Mycostatin and Fungizone on the growth of Histoplasma capsulatum in tissue culture. Journal of Bacteriology 1960; 79: 442–449
- Howard D.H. Intracellular behavior of Histoplasma capsulatum. Journal of Bacteriology 1960; 87: 33–38
- Kurung J.M., Yerigan D. Medium for maintenance and conversion of Histoplasma capsulatum to yeast-like phase. American Journal of Clinical Pathology 1954; 24: 505–508
- Maxwell W.A., Brody G. Antifungal activity of selected benzimidazole compounds. Applied Microbiology 1971; 21: 944–945
- Negroni R., Barbosa W., Komma M.D., Machado O.P. Preliminary study on the action of 2-(4′-thiazolyl)-benzimidazole, a drug with in vitro activity against pathogenic fungi of man. Revista del Instituto de Medicina Tropicale Sao Paulo 1968; 10: 113–117
- Robinson H.J., Phares H.F., Graessle O.E. Antimycotic properties of thiabendazole. Journal of Investigative Dermatology 1964; 42: 479–482
- Robinson H.J., Silber R.H., Graessle O.E. Thiabendazole: Toxicological and pharmacologic and anti-fungal properties. Texas Reports on Biology and Medicine 1964; 27: 537–560
- Saliba N.A. Amphotericin B, basic techniques and dosages for histoplasmosis. Histoplasmosis Proceedings of the Second National Conference, L. Ajello, E.W. Chick, M.L. Furcolow. Charles C. Thomas, Springfield 1971; 395–400, In
- Snedecor G.W., Cochran W.G. Statistical Methods. Iowa State University Press, Ames, Iowa 1967; 102–103
- Thor D.E. The capillary tube migration inhibition technique applied to human peripheral lymphocytes using the guinea pig peritoneal exudate as the indicator cell population. In vitro methods in cell-mediated immunity, B.R. Bloom, P.R. Glade. Academic Press, Inc., New York 1971; 274–279, In
- Zaias N., Rebell G., Restrepo A.M., Ajello L. Enhanced antifungal effect of griseofulvin and thiabendazole in combination. Paracoccidioidomycosis: Proceedings of the First Pan American Symposium. Scientific Publication, No. 254, Pan American Health Organization, World Health Organization. 1971; 163–167, In